Leukemia Clinical Trials in Denver

Showing 701-720 of 1,554 trials

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

NCT05769959

The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, immune response and preliminary anti-tumor activity of RO7515629 alone in participants with advanced or metastatic solid tumors expressing human leukocyte antigen G (HLA-G).

Renal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more

Hoffmann-La Roche3 participantsStarted Jun 2023

Denver, Colorado, United States • Nashville, Tennessee, United States

COMPLETEDPhase 1< 1 mile

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK and immunogenicity, and to preliminarily assess anti-tumor activity of XmAb23104 monotherapy and combination therapy with ipilimumab in subjects with selected advanced solid tumors.

Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more

Xencor, Inc.198 participantsStarted May 2019

San Diego, California, United States • Aurora, Colorado, United States • Denver, Colorado, United States +15 more locations

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Leukemia Trials in Other Cities

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

The clonoSEQ® Watch Registry

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Other Conditions in Denver